424 companies
Marshall Wace Managed Accounts PLC - MW Eureka SRI Fund
Ireland
Marshall Wace Managed Accounts PLC- MW Eureka Fund IV
Ireland
Marshall Wace Managed Accounts PLC-MW TOPS International Equities Fund
Ireland
Marshall Wace UCITS Funds PLC - MW Liquid Alpha UCITS Fund
Ireland
Marshall Wace UCITS Funds PLC-MW TOPS UCITS Fund
Ireland
Mayfair Alternative Credit Funds ICAV
Ireland
MDT
Medtronic Plc
Medtronic plc is an American medical device company.
Ireland
NYSE
Miller Michael Patrick
Ireland
Monroe Capital Opportunistic II Private Credit Intermediate ICAV
Ireland
Monroe Capital Private Credit Intermediate V
Ireland
Monroe Capital Private Credit Intermediate V ICAV
Ireland
MURA
Mural Oncology plc
Mural Oncology is a new, independent publicly traded company with $275M in cash1, providing runway into 4Q 2025. Highly experienced senior leadership team with deep immuno-oncology experience Nemvaleukin is an intrinsically active, stable fusion protein which does not degrade into native-IL-2 and is designed to selectively bind to the intermediate-affinity IL-2 receptor, enabling a potentially enhanced therapeutic window Mural Oncology - Building a Novel Engineered Cytokine Company Nemvaleukin has generated compelling clinical data to date, with durable responses2 in monotherapy and in PD-1 combination across a range of tumor types.
Ireland
NASDAQ
NBRVF
Nabriva Therapeutics plc
nabriva is a clinical-stage biopharmaceutical company engaged in the research and development of novel antibiotics to treat serious infections, with a focus on the pleuromutilin class of antibiotics.
Ireland
NASDAQ
Napier Park Europe Loan Management Designated Activity Co
Ireland
New Capital US Value Fund, a Sub-Fund of New Capital UCITS Fund plc
Ireland
Norselab Meaningful Equity Ii
Ireland
Norselab Meaningful Impact High Yield
Ireland
Norselab Meaningful Structured Equity I
Ireland
Norselab Real Estate Credit Opportunities
Ireland
OAKS Emerging Umbrella Fund plc - Fiera Oaks EM Select Fund
Ireland